Zenas BioPharma, Inc. Common Stock (ZBIO)
Zenas BioPharma, Inc. Common Stock
XNAS:ZBIO
21.34
$21.54 - 5.00
$20.25 - 100.00
$19.02
$21.64
$20.1
$19.78
44.6
5.83
1414526
1889168.1
21934004.65
Chart
TendieTensor AI Analysis
Company
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Fundamentals
130
-4.760000
4.250830
100
BBG01J1MG9D6
BBG01J1MG9F4
42.11M
47.11M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own ZBIO. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.